It's not FDA-approved and it doesn't treat or cure any disease
The Hypothalamus: This area of the brain is the master control centre for appetite and energy balance
There is no absolute contraindication to combining GLP-1 medications with Hashimoto's disease, provided hypothyroidism is adequately managed with levothyroxine replacement
Appetite Suppression : GLP-1 medications act on the brains appetite control centers, particularly the hypothalamus, to reduce hunger and increase feelings of satiety
Research indicates that ibuprofen, like other NSAIDs, may contribute to glutathione depletion under certain conditions
Glucagon-like peptide-1 receptor (GLP-1R) is widely expressed G protein-coupled receptor, mediates the effects of Glucagon-like peptide-1 (GLP-1), a peptide derived from proglucagon and produced in intestinal L-cells, pancreatic -cells, and specific brain regions (22)